Metoprolol and propranolol in the prophylactic treatment of classical and common migraine. A double-blind study

Cephalalgia

Volumn 4, Issue 2, 1984, Pages 91-96

  Kangasniemi, P ^a   Hedman, C ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b Medical Department AC and C of New York City   (United States)

Author keywords

Beta adrenoceptor blockade; metoprolol; migraine; prophylactic treatment; propranolol

Indexed keywords

DURULES; METOPROLOL; PLACEBO; PROPRANOLOL; UNCLASSIFIED DRUG;

CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG THERAPY; HUMAN; MIGRAINE; THERAPY;

ADOLESCENT; ADULT; CLINICAL TRIALS; COMPARATIVE STUDY; DOUBLE-BLIND METHOD; FEMALE; HEMODYNAMICS; HUMAN; LONG-TERM CARE; MALE; METOPROLOL; MIDDLE AGE; MIGRAINE; PROPRANOLOL;

EID: 0021271767     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1046/j.1468-2982.1984.0402091.x     Document Type: Article

References (22)

1. Forssman B Henriksson K-G Johansson V Lindvall L Lundin H. Propranolol for migraine prophylaxis. Headache 1976; 16: 238–45.
2. Weber R Reinmuth O. The treatment of migraine with propranolol. Neurology 1972; 22: 366–9.
3. Diamond S Medina J. Double-blind study of propranolol for migraine prophylaxis. Headache 1976; 16: 24–27.
4. Behan PO Reid R. Propranolol in the treatment of migraine. Practitioner 1980; 224: 201–4.
5. Ekbom K. Alprenolol for migraine prophylaxis. Headache 1975; 15: 129–32.
6. Ekbom K Zetterman M. Oxprenolol in the treatment of migraine. Acta Neurol Scand 1977; 56: 181–4.
7. Nanda RN Johnson RH Gray J Keugh HJ. Meville ID. A double-blind trial of acebutolol for migraine prophylaxis. Headache 1979; 18: 379–81.
8. Sjaastad O Stensrud P. Clinical trial of a beta-receptor blocking agent (LB 46) in migraine prophylaxis. Acta Neurol Scand 1972; 48: 124–8.
9. Briggs RS Millac PA. Timolol in migraine prophylaxis. Headache 1979; 19: 379–81.
10. Standnes B. The prophylactic effect of timolol versus propranolol and placebo in common migraine: beta-blockers in migraine. Cephalalgia 1982; 2: 165–70.
11. Stensrud P Sjaastad O. Comparative trial of Tenormin(r) (atenolol) and Inderal(r) (propranolol) in migraine. Headache 1980; 20: 204–7.
12. Forssman B Lindblad GJ Zbornikova V. Atenolol for migraine prophylaxis. Acta Neurol Scand [Suppl 90] 1982: 75–76.
13. Ljung O. Metoprolol in migraine. Cephalalgia 1981; 1: 142.
14. Andersson P-G Dahl S Hansen JH Hansen PE Hedman C Nygaard Kristensen T de Fine Olivarius B. Prophylactic treatment of classical and non-classical migraine with metoprolol-a comparison with placebo. Cephalalgia 1983; 3: 207–12.
15. Third Migraine Symposium April 1969. Background to Migraine. Ed by Cochrane A. L., London: Heineman, 1970: 180–1.
16. Johnsson G Jordö L Lundborg P Regårdh C-G Rönn O. Plasma levels and pharmacological effects of metoprolol administered as controlled release (Durules(r)) and ordinary tablets in healthy volunteers. Int J Clin Pharmacol Ther Toxicol 1980; 18: 292–7.
17. Editorial. Br Med J 1977; 1: 793.
18. Rosen JA. Observations on the efficacy of propranolol for the prophylaxis of migraine. Ann Neurol 1983; 13: 92–93.
19. Galbo H Christensen N J Hoist JJ. Glucose-induced decrease in glucagon and epinephrine responses in man. Appl Physiol 1977; 42: 525–30.
20. Lundborg P åström H Bengtsson C Fellenius E von Schenck H Svensson L Smith U. Effect of b-adrenoceptor blockade on exercise performance and metabolism. Clin Sci 1981; 61: 299–305.
21. Kendall MJ. Are selective beta-adrenoceptor-blocking drugs an advantage? J Roy Coll Phys (London) 1981; 15: 33–40.
22. Gotoh F Kanda T Sakai F Yamamoto M Takeoka T. Serum dopamine-ß-hydroxylase activity in migraine. Arch Neurol 1976; 33: 656–7.